Re: "Effect of long-term treatment with strontium ranelate on bone strontium content" by Bärenholdt et al. (Bone, 2009)

Bone

Volumn 45, Issue 5, 2009, Pages 1024-1025

  Belissa Chatelain, Patricia ^a   Dupin Roger, Isabelle ^a   Cournarie, Fabienne ^a   Tsouderos, Yannis ^a  

^a IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STRONTIUM RANELATE;

BONE BIOPSY; BONE DENSITY; BONE MASS; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG BONE LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG MONITORING; DRUG UPTAKE; FOLLOW UP; HIP FRACTURE; HUMAN; LETTER; LONG TERM CARE; LUMBAR SPINE; NONHUMAN; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; RISK REDUCTION; VERTEBRA FRACTURE;

ABSORPTIOMETRY, PHOTON; BARIUM; BONE AND BONES; BONE DENSITY; FEMALE; HUMANS; MODELS, BIOLOGICAL; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS; REPRODUCIBILITY OF RESULTS; STRONTIUM; THIOPHENES; TIME FACTORS;

EID: 70349284448     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.07.004     Document Type: Letter

References (15)

1. Bärenholdt O, Kolthoff N, Pors Nielsen S. Effect of long-term treatment with strontium ranelate on bone strontium content. Bone 2009 Aug;65(2):200-6.
2. Pors Nielsen S., Barenholdt O., Barenholdt-Schioler C., Mauras Y., and Allain P. Non invasive measurement of bone strontium. J. Clin. Densitom. 7 (2004) 262-268
3. Meunier P.J., Slosman D., Delmas P.D., Sebert J.L., Brandi M.L., Albanese C., et al. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis: a 2-year, randomised, placebo-controlled trial. J. Clin. Endocrinol. Metab. 87 5 (2002) 2060-2206
4. Bruyere O., Roux C., Badurski J., Isaia G., De Vernejoul M.C., Cannata J., et al. Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate. Curr. Med. Res. Opin. 23 12 (2007) 3041-3045
5. Bruyère O., Roux C., Detilleux J., Slosman D.O., Spector T., Fardellone P., et al. Relation between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J. Clin. Endocrinol. Metab. 92 (2007) 3076-3081
6. Bouxsein M.L., Parker R.A., and Greenspan S.L. Forearm bone mineral densitometry cannot be used to monitor response to alendronate therapy in postmenopausal women. Osteoporos. Int. 10 6 (1999) 505-509
7. Kendler D, Adachi J, Josse R, Slosman D. Monitoring strontium ranelate therapy in patients with osteoporosis. Osteoporos Int 2009;20:1101-6.
8. Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P. et al. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporos Int in press. doi:10.1007/s00198-008-0825-6.
9. Farlay D., Boivin G., Panczer G., Lalande A., and Meunier P.J. Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone. J. Bone Miner. Res. 20 9 (2005) 1569-1578
10. Marshall J.H. The power function model. In: Comar C.L., and Bronner F. (Eds). Mineral Metabolism, and Advance Treatise Vol III (1969), Academic Press, New York and London
11. Marshall J.H., Lloyd E.L., Rundo J., Liniecki J., Marotti G., Mays C.W., et al. Alkaline earth metabolism in adult man. A report prepared by a task group of Committee 2 of the International Commission on Radiological Protection (ICRP Publication 20). Health Phys. 24 (1973) 129-221
12. Lin Y., Hillegonds D.J., Gertz E.R., Van Loan M.D., and Vogel J.S. Protocol for assessing bone health in humans by tracing long-lived 41Ca isotope in urine, serum, and saliva samples. Anal. Biochem. 332 (2004) 193-195
13. Meunier P.J., Roux C., Seeman E., Ortolani S., Badurski J., Spector T., et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N. Engl. J. Med. 350 5 (2004) 459-468
14. Reginster J.Y., Seeman E., De Vernejoul M.C., Adami S., Compston J., Phenekos C., et al. Strontium ranelate reduces the risk of nonvertebral fractures in post-menopausal women with osteoporosis: TROPOS Study. JCEM 90 5 (2005) 2816-2822
15. Blake G.M., and Fogelman I. Bone densitometry: an update. Editorial. Lancet 366 9503 (2005) 2068-2070